1. The above information is based on the products, ATP-C130 obtained FDA, CE MDD(Medical Devices Directive), PMDA in Japan, MFDS in South Korea and ATP-C70 obtained PMDA in Japan, MFDS in South Korea. Thus, the information is specifically for South Korea & Europe and can differ with countries.
2. AT-Note(App) is usable only if you own a compatible smartphone or tablet. And the usage time of AT-Patch may be affected, depending on the individual communication environment for AT-Note’s Live ECG. For more information, please refer to the user manual.
3. AT-Report(PC S/W) is software for medical institutions, not provided patients directly. Patients can review the analysis result with or from your doctor.
4. The above information can be updated repeatedly.